Browse > Article
http://dx.doi.org/10.17555/jvc.2017.10.34.5.341

Retinal Function Analysis and Histopathologic Assessment after Intravitreal Cidofovir Injection in Normal Beagle Dogs  

Park, Sungwon (Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Seoul National University)
Kang, Seonmi (Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Seoul National University)
Park, Sangwan (Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Seoul National University)
Han, Jiseok (Pathology Research Center, Korea Institute of Toxicology)
Kim, Yongbum (Pathology Research Center, Korea Institute of Toxicology)
Seo, Kangmoon (Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Seoul National University)
Publication Information
Journal of Veterinary Clinics / v.34, no.5, 2017 , pp. 341-346 More about this Journal
Abstract
This study was performed to evaluate the effects of an intravitreal injection of cidofovir in beagle dogs. Nine beagle dogs (18 eyes) were used and randomly assigned to the following three groups of various dosages: 100, 500 and $1000{\mu}g$. Aqueous paracentesis was followed by an intravitreal injection of cidofovir. Intraocular pressure (IOP) was measured twice a week and electroretinography (ERG) and ophthalmoscopic examination were performed every week during the study. At the end of the study, all eyes were enucleated for histopathologic evaluation after euthanasia. The IOPs in the 500 and $1000{\mu}g$ groups were statistically lower than baseline with no significant IOP changes in the $100{\mu}g$ group. Reduced amplitudes of ERG recordings were identified in the eyes injected with higher dose groups than the $100{\mu}g$ group. Histopathologic examination revealed that there were dose-related toxicities to the ciliary body and the retina. These results suggest that intravitreal cidofovir had dose-dependent IOP lowering effects associated with ciliary body destruction, but had the potential to cause retinal toxicity in beagle dogs.
Keywords
cidofovir; chemical ablation; IOP; glaucoma; dog;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Garneau M, Bolger GT, Bousquet C, Kibler P, Tremblay F, Cordingley MG. HPMPC therapy of MCMV-induced retinal disease in the SCID mouse measured by electroretinography, a non-invasive technique. Antiviral Res 2003; 59: 193-200.   DOI
2 Gelatt KN, Plummer CE, Regnier A. The Canine Glaucoma. In: Vet ophthalmol, 5th ed. Ames, John Willey & Sons. 2013: 1050-1129.
3 Gilger BC, Reeves KA, Salmon JH. Ocular parameters related to drug delivery in the canine and equine eye: aqueous and vitreous humor volume and scleral surface area and thickness. Vet Ophthalmol 2005; 8: 265-8269.   DOI
4 Kirsch LS, Arevalo JF, Chavez de la Paz E, Munguia D, de Clercq E, Freeman WR. Intravitreal cidofovir (HPMPC) treatment of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Vet ophthalmol 1995; 102: 533-543.   DOI
5 Low MC, Landis ML, Peiffer RL. Intravitreal cidofovir injection for the management of chronic glaucoma in dogs. Vet Ophthalmol 2014; 17: 201-206.   DOI
6 Maggs DJ, Miller PE, Ofri R. Slatter's fundamentals of veterinary ophthalmology. 5th ed. Saunders, Elsevier. 2013: 251-271.
7 Masur H, Whitcup SM, Cartwright C, Polis M, Nussenblatt R. Advances in the management of AIDS-related cytomegalovirus retinitis. Ann Intern Med 1996; 125: 126-136.   DOI
8 Rahhal FM, Arevalo JF, Munguia D, Taskintuna I, Chavez de la Paz E, Azen SP, Freeman WR. Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis. Vet ophthalmol 1996; 103: 1078-1083.   DOI
9 Taskintuna I, Banker AS, Rao NA, Wiley CA, Flores- Aguilar M, Munguia D, Bergeron-Lynn G, De Clercq E, Keefe K, Freeman WR. An animal model for cidofovir (HPMPC) toxicity: Intraocular pressure and histopathologic effects. Exp Eye Res 1997; 64: 795-806.   DOI
10 Taskintuna I, Rahhal FM, Arevalo JF, Munguia D, Banker AS, De Clercq E, Freeman WR. Low-dose intravitreal cidofovir (HPMPC) therapy of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Vet ophthalmol 1997; 104: 1049-1057.   DOI
11 Taskintuna I, Rahhal FM, Rao NA, Willey CA, Mueller AJ, Banker AS, De Clercq E, Arevalo JF, Freeman WR. Adverse events and autopsy findings after intravitreous cidofovir (HPMPC) therapy in patients with acquired immune deficiency syndrome (AIDS). Vet ophthalmol 1997; 104: 1827-1837.   DOI
12 Bedford PG. Retinal pigment epithelial dystrophy in the Briard. Vet Rec 2009; 12: 377.
13 Young RW. Pathophysiology of age-related macular degeneration. Surv Ophthalmol 1987; 31: 291-306.   DOI
14 Zarbin MA. Pathogenesis of Age-Related Macular Degeneration. In: Med Retina. Karger, Basel. 2012; 1: 125-133.
15 Aguirre GD, Laties A. Pigment epithelial dystrophy in the dog. Exp Eye Res 1976; 23: 247-256.   DOI
16 Banker AS, Arevalo JF, Munguia D, Rahhal FM, Ishimoto B, Berry C, De Clercq E, Ochabski R, Taskintuna I, Freeman WR. Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis. Am J Ophthalmol 1997; 124: 168-180.   DOI
17 Banker AS, De Clercq E, Taskintuna I, Keefe KS, Bergeron-Lynn G, Freeman WR. Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes. Invest Ophthalmol Vis Sci 1998; 39: 1233-1242.
18 Davidson MG, Geoly FJ, Gilger BC, McLellan GJ, Whitley W. Retinal degeneration associated with vitamin E deficiency in hunting dogs. J Am Vet Med Assoc 1998; 5: 645-651.
19 Ekesten B, Ophthalmic Examination and Diagnostics. In: Vet ophthamol, 5th ed. Ames, John Willey & Sons. 2013: 684-685.